View in EDS

Correlation Between the Rutgeerts Score and Clinical Recurrence in Crohn’s Disease

Saved in:
Bibliographic Details
Title: Correlation Between the Rutgeerts Score and Clinical Recurrence in Crohn’s Disease
Authors: Tamdaoui, Meriem, Mechhor, Salma, Malki, Manal Cherkaoui, Bacha, Hicham El, Benzzoubeir, Nadia, Errabih, Ikram
Source: International Journal of Science and Research Archive. 16:1051-1056
Publisher Information: GSC Online Press, 2025.
Publication Year: 2025
Subject Terms: Risk Stratification, Postoperative Recurrence, Crohn's Disease, Endoscopy, Rutgeerts Score
Description: Crohn’s disease frequently recurs after ileocolic resection, with endoscopic lesions often preceding clinical relapse. The Rutgeerts score, widely used to evaluate postoperative recurrence, provides a reliable measure of mucosal healing and disease activity. In this retrospective study including 92 patients operated at Ibn Sina University Hospital between 2019 and 2025, we assessed the correlation between postoperative Rutgeerts scores and clinical outcomes during a three-year follow-up. Endoscopic recurrence (Rutgeerts ≥ i2) was observed in 45.6% of patients, while 39.1% developed clinical relapse. Recurrence rates increased progressively with higher scores, ranging from 4.5% in i0 to 100% in i4. Notably, the subclassification of i2 lesions revealed distinct prognostic implications, with clinical relapse occurring in 18.7% of i2a versus 75% of i2b patients. Multivariate analysis identified a Rutgeerts score ≥ i2 as the only independent predictor of recurrence (aOR 3.2, 95% CI 2.6–28; p < 0.001). These findings confirm the strong association between endoscopic and clinical recurrence, highlight the clinical relevance of the i2a/i2b distinction, and support the role of the Rutgeerts score as a key tool in postoperative risk stratification and therapeutic decision-makin.
Document Type: Article
ISSN: 2582-8185
DOI: 10.30574/ijsra.2025.16.2.2429
DOI: 10.5281/zenodo.17285178
DOI: 10.5281/zenodo.17285179
Rights: CC BY
Accession Number: edsair.doi.dedup.....b4a9a87fbc21fbdfa846df9388687ca9
Database: OpenAIRE
Description
Abstract:Crohn’s disease frequently recurs after ileocolic resection, with endoscopic lesions often preceding clinical relapse. The Rutgeerts score, widely used to evaluate postoperative recurrence, provides a reliable measure of mucosal healing and disease activity. In this retrospective study including 92 patients operated at Ibn Sina University Hospital between 2019 and 2025, we assessed the correlation between postoperative Rutgeerts scores and clinical outcomes during a three-year follow-up. Endoscopic recurrence (Rutgeerts ≥ i2) was observed in 45.6% of patients, while 39.1% developed clinical relapse. Recurrence rates increased progressively with higher scores, ranging from 4.5% in i0 to 100% in i4. Notably, the subclassification of i2 lesions revealed distinct prognostic implications, with clinical relapse occurring in 18.7% of i2a versus 75% of i2b patients. Multivariate analysis identified a Rutgeerts score ≥ i2 as the only independent predictor of recurrence (aOR 3.2, 95% CI 2.6–28; p < 0.001). These findings confirm the strong association between endoscopic and clinical recurrence, highlight the clinical relevance of the i2a/i2b distinction, and support the role of the Rutgeerts score as a key tool in postoperative risk stratification and therapeutic decision-makin.
ISSN:25828185
DOI:10.30574/ijsra.2025.16.2.2429